Company Data
Scinai Immunotherapeutics Ltd.
Ticker
SCNI
Current Price
$0.7524 -16.54%
Market Cap
$1.0M
Price Target
Refer to Report
Volume
217.7K
52wk Range
$0.75 - $15.65
Overview
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.